U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07157085) titled 'AI Multitask Model for HCC Treatment' on Aug. 28.
Brief Summary: We will integrate multi-modal cardiac data via an AI multitask framework to develop and validate concurrent models for liver function, treatment prognosis, and microvascular invasion (MVI) prediction in hepatocellular carcinoma. The resulting tool will be prospectively deployed to guide personalized surgical, TACE, and systemic therapy decisions.
Study Start Date: Jan. 01, 2008
Study Type: OBSERVATIONAL
Condition:
Hepatocellular Carcinoma (HCC)
Intervention:
OTHER: Comprehensive treatment
Comprehensive HCC therapies include liver resection, TACE, HAIC, targeted ...